Statistics for Elevation Oncology, (id:8427 ELEV)
Valuation metrics
Market cap
35.67M
Enterprise value
-36,270,148.00
Trailing P/E (ttm)
-0.45
Forward P/E
-0.66
PEG ratio
-0.66
Price/Sales (ttm)
Price/Book (mrq)
0.51
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.86
Overview
Shares outstanding
59.12M
Float
41.07M
Shares short
6.21M
% Held by insiders
0.00%
% Held by institutions
0.78%
Average volume (10 days)
575.04K
Average volume (90 days)
Price summary
52-Week low
0.44
52-Week high
5.83
52-Week change
20.90%
Beta
1.25
50-Day moving average
0.58
200-Day moving average
2.45
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-25.46%
Return on equity
-63.67%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-41,978,000.00
Net income to common (ttm)
-41,948,000.00
Diluted EPS (ttm)
-0.80
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
103.07M
Total cash per share (mrq)
1.74
Total debt (mrq)
31.02M
Total Debt/Equity (mrq)
44.73
Current ratio (mrq)
1.78K%
Book value per share (mrq)
1.17
Cash flow
Cash flow statement
-38,343,000.00
Levered free cash flow (LFCF)
-25,368,000.00